A staggering 800% increase in licensing agreement deal values for messenger ribonucleic acid (mRNA)-based innovator ...

RNA-based vaccines, which instruct cells to produce proteins that can prevent or treat disease, show great promise in ...

Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest ...

Domestic pharmaceutical companies say losing patent rights flexibilities will make medicines more expensive, as producing ...

Strategic Collaboration to Address Critical Healthcare Needs and Expand Access to Life-Changing Treatments ...

Eli Lilly (NYSE: LLY) plans to invest $206M to expand its Suzhou, China site for Type 2 diabetes and obesity drugs. The ...

and has been granted a new cultivation license by Health Canada. Production is expected to begin in early 2025, marking ...

Large pharmaceutical companies were out in force at this week’s 2024 Cell & Gene Meeting on the Mesa, as they look to expand ...

India’s pharmaceutical industry is projected to hit $42.9b by 2028 with a compound annual growth rate of 6.3% in local ...

Teva Pharmaceuticals International GmbH, a unit of Teva Pharmaceutical Industries (TEVA) and mAbxience, a Fresenius Kabi ...

Report Ocean, a leading strategic consulting and market research firm, in its recent study, estimated the Global Pharmaceutical Excipients Market size at USD 8.89 billion in 2023. During the forecast ...